CION Ameerpet
Immunotherapy Side Effects · Heart, Kidney, Muscle & Nerve Reactions
Numbness, Tingling and Nerve Problems on Immunotherapy — What's Normal, What's Urgent, and What to Do Next
Numbness or tingling on immunotherapy is usually a mild, common sensory symptom that improves on its own. In a small number of patients, though, nerve symptoms can be the first sign of a rare, fast-moving immune reaction that resembles Guillain-Barré syndrome. NCCN and ASCO guidance on immune-related adverse events treats numbness or tingling that is spreading, worsening quickly, or affecting breathing or walking as an emergency, not a symptom to wait out.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Usually mild — most numbness or tingling during immunotherapy is a common, low-grade sensory symptom that settles with monitoring.
- Rare, but can turn serious — nerve reactions can occasionally progress to a Guillain-Barré-like pattern affecting breathing within days.
- Easy to dismiss — early tingling in the fingers or toes is often mistaken for harmless pins-and-needles.
- Go to the ER for red flags — spreading weakness, breathing or swallowing difficulty need emergency care immediately.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Symptom triage
How Urgent Is Numbness or Tingling on Immunotherapy?
Most numbness or tingling during immunotherapy is mild and stays confined to the fingers or toes — it is common and usually not dangerous. It becomes urgent when it spreads quickly, involves both sides equally, or comes with weakness, breathing difficulty or trouble walking, because this pattern can point to a rare, fast-moving immune reaction affecting the nerves.
Go to the ER now, or call an ambulance, if numbness or tingling comes with any of these:
- Weakness that is spreading upward from the feet or hands
- Difficulty breathing, or a change in your breathing pattern
- Difficulty walking, standing, or a sudden loss of balance
- Facial weakness, slurred speech, or difficulty swallowing
For any other new or persistent numbness or tingling during immunotherapy, call the CION helpline the same day:
Call the CION Helpline Now: 1800 202 8726
Know the difference
What's the Difference Between Mild Neuropathy and a Serious Nerve Reaction?
Mild sensory neuropathy usually causes tingling or numbness that stays in the fingertips or toes, comes on slowly, and does not affect strength or walking. A serious reaction — sometimes resembling Guillain-Barré syndrome — usually spreads upward over days, affects both sides symmetrically, and comes with weakness, unsteady walking, or breathing changes.
| Feature | Mild sensory neuropathy (common) | Guillain-Barré-like reaction (rare, urgent) |
|---|---|---|
| Pattern | Tingling or numbness confined to fingertips or toes | Weakness and numbness spreading upward from feet or hands, often symmetric |
| Onset | Comes on gradually, stays roughly the same day to day | New or worsening over hours to days, sometimes rapidly |
| Strength | Not affected — grip and walking stay normal | Progressive weakness, unsteady walking, or difficulty standing |
| Associated signs | None specific | Facial weakness, slurred speech, swallowing or breathing difficulty |
| Everyday tasks | Manageable, sensation slightly altered | Newly unable to walk steadily, grip objects, or breathe comfortably |
Timing and recovery
How Soon Does Nerve Numbness Appear, and Does It Recover?
Nerve symptoms most often begin within the first few months of checkpoint-inhibitor immunotherapy, though they can appear at any stage. Mild sensory neuropathy usually improves gradually once it is monitored and, if needed, immunotherapy is adjusted — but recovery from a Guillain-Barré-like reaction depends heavily on how early it is caught and treated, which is why prompt reporting matters more than the exact timeline.
| Stage | What's typically happening |
|---|---|
| Typically starts | Most often within the first few months of checkpoint-inhibitor immunotherapy — though it can occur earlier or later, including after treatment ends. |
| Early phase | Mild tingling or numbness in the fingertips or toes, often symmetric and slowly progressive — easy to mistake for a minor, unrelated cause. |
| If rapidly progressing | Can spread upward, involve both sides, and progress to weakness or breathing difficulty within days, resembling a Guillain-Barré-like reaction. |
There is no safe home-management step for numbness or tingling that comes with spreading weakness, breathing difficulty or trouble walking during immunotherapy. Because a Guillain-Barré-like reaction can progress within days, the correct response is always the same: get it checked immediately, or go to the ER for the emergency signs above.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Don't Wait Out New Numbness or Weakness on Immunotherapy
Our tumour board includes the same specialists managing your immunotherapy — reach them directly.
What comes after you call
How Immune-Related Neuropathy Is Diagnosed and Treated
Reporting new numbness or tingling early leads to a structured neurological assessment, not guesswork — the pattern, spread and strength are checked before deciding whether this is mild sensory neuropathy or a reaction needing urgent treatment.
- 1
Neurological examination
A check of strength, reflexes and sensation pattern to see how the nerves are affected, and whether the symptom is confined to sensation or also involves movement.
- 2
Ruling out other causes
Diabetes, prior chemotherapy-related neuropathy, vitamin B12 deficiency and thyroid problems are checked before attributing new numbness to immunotherapy.
- 3
Nerve conduction studies
For spreading or significant weakness, a neurologist may order nerve conduction studies (NCS) or electromyography (EMG) to confirm the pattern.
- 4
Steroids or immune-modulating treatment
Confirmed immune-mediated neuropathy usually starts with high-dose steroids; a Guillain-Barré-like reaction may need IVIG or plasma exchange and close, sometimes ICU-level, monitoring.
- 5
Decision on immunotherapy
Depending on severity and whether the reaction is sensory-only or involves weakness, your tumour board decides whether immunotherapy can continue, needs a pause, or should be stopped for that patient.
Care during treatment
Rare Nerve Reactions Are Manageable When Caught Early
Patients who report new numbness or tingling immediately are supported by the same multidisciplinary team throughout treatment.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Numbness, Tingling and Nerve Problems: Your Questions Answered
Is numbness or tingling common during immunotherapy?
Yes — mild numbness or tingling in the fingertips or toes is a fairly common sensory symptom during checkpoint-inhibitor immunotherapy and is usually not dangerous on its own. It typically stays confined to a small area, develops gradually, and does not affect muscle strength or walking. What matters is the pattern: numbness that spreads quickly, involves both sides equally, or comes with weakness is far less common and needs prompt medical review rather than being assumed to be routine.
Which numbness or tingling patterns are urgent?
A pattern is urgent when numbness or tingling spreads upward from the hands or feet over hours to days, affects both sides symmetrically, or comes with weakness, unsteady walking, breathing difficulty, facial weakness or trouble swallowing. This combination can point to a rare, Guillain-Barré-like immune reaction that can progress to affect breathing within days. NCCN and ASCO guidance on immune-related adverse events treats this pattern as an emergency requiring same-day, and sometimes immediate, medical attention.
What does mild sensory neuropathy feel like?
Mild sensory neuropathy usually feels like tingling, pins-and-needles or numbness confined to the fingertips or toes. It tends to come on gradually, stays roughly the same from day to day, and does not affect muscle strength, walking or breathing. It is often mistaken for harmless causes such as sitting awkwardly or mild vitamin deficiency, which is why any new nerve symptom during immunotherapy is still worth mentioning to your care team, even if it seems minor.
What is a Guillain-Barré-like reaction, and why is it different?
A Guillain-Barré-like reaction is a rare immune-related nerve reaction that can occur during checkpoint-inhibitor immunotherapy, in which the immune system affects the nerves controlling movement as well as sensation. Unlike mild sensory neuropathy, it usually spreads upward from the feet or hands over days, affects both sides symmetrically, and can progress to weakness, unsteady walking or breathing difficulty. Because it can become serious quickly, it is treated as a medical emergency, not monitored at home.
Does nerve numbness from immunotherapy recover?
Mild sensory neuropathy usually improves gradually, often over weeks to months, once it is monitored and, if needed, immunotherapy is paused or adjusted. Recovery from a Guillain-Barré-like reaction depends heavily on how early it is recognised and treated — patients treated promptly with steroids, IVIG or plasma exchange generally do better than those whose symptoms progress before treatment starts, which is why early reporting matters more than the exact recovery timeline.
What should I do if I notice new numbness or tingling on immunotherapy?
Call the CION helpline the same day you notice new numbness or tingling during immunotherapy — do not wait to see if it settles on its own. Go to the nearest emergency room immediately if it comes with spreading weakness, difficulty breathing, trouble walking, facial weakness, slurred speech or difficulty swallowing, since these point to the rare nerve reactions that need urgent treatment.